Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer

Dr Hope Rugo - University of California San Francisco, San Francisco, USA

Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )

Cancer Services Delivery: Focus on India

Dr Soumitra Datta - Tata Medical Center, Kolkata, India

Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )

Diagnostic performance and survival outcome of SLNB procedure in breast cancer...

Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India

Diagnostic performance and survival outcome of SLNB procedure in breast cancer patients from a tertiary cancer care centre ( Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India )

War in Ukraine: Impacts on the Ukrainian cancer care system

Dr Andriy Hrynkiv - Lviv Regional Cancer Centre of Ukraine, Lviv, Ukraine

War in Ukraine: Impacts on the Ukrainian cancer care system ( Dr Andriy Hrynkiv - Lviv Regional Cancer Centre of Ukraine, Lviv, Ukraine )

Recurrent non-invasive breast tumours may not always be related to the primary...

Dr Tanjina Kader - University of Melbourne, Melbourne, Australia

Recurrent non-invasive breast tumours may not always be related to the primary lesion ( Dr Tanjina Kader - University of Melbourne, Melbourne, Australia )

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1...

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer...

Dr Diana Artene - American Society for Nutrition, Bucharest, Romania

Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients ( Dr Diana Artene - American Society for Nutrition, Bucharest, Romania )

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Eye metastasis in breast cancer: Case report and review of literature

Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt

Eye metastasis in breast cancer: Case report and review of literature ( Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt )

Update on the new EUSOMA quality indicators for breast cancer

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

Update on the new EUSOMA quality indicators for breast cancer ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )

The optimal approach after neoadjuvant treatment: The Lucerne toolbox

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )

Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs...

Prof Peter Schmid - Queen Mary University of London, London, United Kingdom

Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs placebo for early-stage TNBC ( Prof Peter Schmid - Queen Mary University of London, London, United Kingdom )

More from ecancer